Figure 4From: First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation studyRates of patients with a dose intensity not more than 85% of planned by first-cycle nadir ANC in the MDACC sample. Numbers of patients are shown above bars.Back to article page